9th Circ. Revives Claims That Medtronic Skirted FDA Review

By Dorothy Atkins · April 5, 2021, 9:48 PM EDT

The Ninth Circuit on Friday revived allegations from a whistleblower's suit that Medtronic fraudulently obtained U.S. Food and Drug Administration clearance for certain spinal surgery implants, but affirmed the dismissal of other...

To view the full article, register now.

Documents

Case Information

Case Title

The Dan Abrams Company, et al v. Medtronic Inc., et al

Case Number

19-56377

Court

Appellate - 9th Circuit

Nature of Suit

3375 Other Statutes - False Claims Act

Date Filed

November 25, 2019